이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Astec LifeSciences 대차 대조표 상태
재무 상태 기준 확인 2/6
Astec LifeSciences 의 총 주주 지분은 ₹3.7B 이고 총 부채는 ₹4.9B, 이는 부채 대 자기자본 비율을 133.7% 로 가져옵니다. 총자산과 총부채는 각각 ₹9.7B 및 ₹6.1B 입니다.
주요 정보
133.7%
부채 비율
₹4.94b
부채
이자 보상 비율 | n/a |
현금 | ₹4.72m |
주식 | ₹3.70b |
총 부채 | ₹6.05b |
총 자산 | ₹9.75b |
최근 재무 상태 업데이트
Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
Nov 27Recent updates
Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package
Jul 23Market Participants Recognise Astec LifeSciences Limited's (NSE:ASTEC) Revenues Pushing Shares 28% Higher
Jul 03Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable
Mar 15Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital
May 17Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value
Oct 14We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Jul 27Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)
Jun 03Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)
May 08Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 06Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 25Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet
Jul 21Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested
Apr 17Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?
Apr 02Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?
Mar 18Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?
Mar 05Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?
Feb 20A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration
Feb 08Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?
Jan 28What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?
Jan 17Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 08I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Dec 28Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?
Dec 18Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?
Dec 07Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
Nov 27Ashok Hiremath Is The MD & Director of Astec LifeSciences Limited (NSE:ASTEC) And They Just Sold 35% Of Their Shares
Nov 17재무 상태 분석
단기부채: ASTEC 의 단기 자산 ( ₹4.0B )이 단기 부채( ₹4.0B ).
장기 부채: ASTEC 의 단기 자산( ₹4.0B )이 장기 부채( ₹2.1B ).
부채 대 자본 내역 및 분석
부채 수준: ASTEC 의 순부채 대 자기자본 비율( 133% )은 높음으로 간주됩니다.
부채 감소: ASTEC 의 부채 대 자기자본 비율은 지난 5년간 86.6% 에서 133.7% 로 증가했습니다.
부채 범위: ASTEC 의 부채는 영업 현금 흐름 ( 2.1% )에 의해 잘 갚지 않음입니다.
이자 보장: ASTEC 의 부채에 대한 이자 지급이 EBIT에 의해 잘 충당되었는지 판단할 데이터가 부족합니다.